Seval Beykan Selected Research

gallium 68 PSMA-11

8/2015	68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
6/2015	Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seval Beykan Research Topics

Disease

5	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019 - 07/2016
4	Neoplasms (Cancer) 07/2018 - 08/2015
3	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 06/2015
1	Neoplasm Metastasis (Metastasis) 08/2015

Drug/Important Bio-Agent (IBA)

3	Radioisotopes (Radionuclides)IBA 01/2017 - 07/2016
3	Peptide Receptors (Peptide Receptor)IBA 01/2017 - 07/2016
3	AntigensIBA 11/2016 - 06/2015
2	Peptides (Polypeptides)IBA 01/2018 - 11/2016
2	gallium 68 PSMA-11IBA 08/2015 - 06/2015
1	177Lu-DOTA-JR11IBA 01/2019
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2019
1	Lutetium-177IBA 01/2018
1	Gallium-68IBA 01/2018
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018
1	Fluorine-18IBA 01/2018
1	68Ga-pentixaforIBA 01/2017
1	Blood Proteins (Serum Proteins)IBA 01/2017
1	Chemokine ReceptorsIBA 01/2017
1	aluminum fluorideIBA 11/2016
1	(18)F-PSMA-11IBA 11/2016
1	PSMA I&TIBA 08/2015

Therapy/Procedure

5	Therapeutics 07/2018 - 07/2016
1	Precision Medicine 01/2017
1	Castration 08/2015